Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Byung Il Kim.
Nuclear Medicine and Molecular Imaging | 2012
Jae Pil Hwang; Ilhan Lim; Kyoung Jin Chang; Byung Il Kim; Chang Woon Choi; Sang Moo Lim
PurposeRecent studies have been conducted on the relationship between fluorodeoxyglucose (FDG) uptake in F-18 FDG PET/CT and prognosis in patients with pancreatic cancer, but these studies have been carried out in small numbers of patients. The aim of this retrospective study was to determine in a large number of patients whether glucose metabolism as assessed by F-18 FDG PET/CT provides prognostic information independent of established prognostic factors in patients with pancreatic cancer.MethodsWe reviewed retrospectively the medical records of 165 patients (men 105, women 60, mean age 67u2009±u200910xa0years) with a diagnosis of pancreatic cancer that had undergone F-18 FDG PET/CT as part of a pretreatment workup from January 2004 to December 2009. Subsequently, all patients underwent surgery, cyberknife, radiotherapy, and/or chemotherapy. For the analysis, patients were classified by age, demographic data, maximum standardized uptake value (SUVmax), size, location, serum level of CA19-9, type of treatment, and AJCC stage. The relationship between FDG uptake and survival was analyzed using the Kaplan-Meier with log-Rank test and Cox’s proportional-hazard regression methods.ResultsMedian survival for all 165 study subjects was 290xa0days and median SUV by PET/CT was 5.8 (range: 0–25.1). Patients were allocated to high (>u20094.1) and low (≤4.1) SUV groups, and median survivals of these patients were 229xa0days and 610xa0days, respectively, which were significantly different (pu2009<u20090.0001). Furthermore, SUVmax was found to be significantly related to survival in each stage, i.e., there were 1267xa0days in stage I, 440xa0days in stage II, 299xa0days in stage III, and 143xa0days in stage IV (pu2009<u20090.0001). The median survival was also found to be significantly related to tumor size (pu2009=u20090.001), site (pu2009=u20090.0298), serum level of CA19-9 (pu2009=u20090.0017), distant metastasis (pu2009<u20090.0001), and type of treatment (pu2009<u20090.0001). Multivariate analysis study revealed that the patients with a low SUV (pu2009=u20090.0298), a lower serum level of CA19-9 (pu2009=u20090.0071), a lower stage (pu2009=u20090.0017), and no distant metastasis (pu2009<u20090.0001) had longer survivals. In addition, SUVmax values were found to have a similar hazard ratio of distant metastasis; it was well known predictor. Furthermore, SUVmax values showed a higher hazard ratio than that of other clinicopathologic predictors.ConclusionThe present study shows that SUVmax on F-18 FDG PET/CT can provide a prognostic information in patients with pancreatic cancer.
Journal of Korean Endocrine Society | 2007
Won Bae Kim; Tae Yong Kim; Hyuk-Sang Kwon; Won-Jin Moon; Jae Bok Lee; Young Sik Choi; Seok Ki Kim; Sun Wook Kim; Ki Wook Chung; Jung Hwan Baek; Byung Il Kim; Do Joon Park; Dong Gyu Na; Jun Ho Choe; Jae Hoon Chung; Hye Seung Jung; Jeong Han Kim; Kee-Hyun Nam; Hang Seok Chang; Woong Youn Chung; Soon Won Hong; Suck Joon Hong; Jeong Hyun Lee; Ka Hee Yi; Young Suk Jo; Ho-Cheol Kang; Minho Shong; Jin Woo Park; Jong Ho Yoon; Seong Joon Kang
Journal of Korean Thyroid Association | 2013
Won Bae Kim; Ju Won Seok; Min-Hee Kim; Byung Il Kim; Young Joo Park; Kyu Eun Lee; Song Mi Lee; Yong Sang Lee; Kyu Hwan Jung; Young Suk Jo; Gi Jeong Cheon; Jae Hoon Chung; Seong-Joon Kang
Journal of Korean Thyroid Association | 2012
Sungmin Kang; Byung Il Kim; In-Ju Kim; Hee-Seung Bom; Ga Hee Lee; Jaetae Lee; Woong Youn Chung; Jae Hoon Chung
Nuclear Medicine and Molecular Imaging | 2008
Joon Hyuk Choi; Hoon Il Kim; Jang Won Park; Eun Hoon Song; Bong Jin Ko; Gi Jeong Cheon; Byung Il Kim
Journal of Gastric Cancer | 2002
Gi Jeong Cheon; Byung Il Kim; Sang Moo Lim
The Journal of Nuclear Medicine | 2012
Joon Yeun Park; Ilhan Lim; Soo Youn Cho; Byung Il Kim; Chang Woon Choi; Sang Moo Lim
The Journal of Nuclear Medicine | 2011
Jae Pil Hwang; Ilhan Lim; Byung Il Kim; Im Il Na; Eung Ho Cho; Chang Woon Choi; Sang Moo Lim
The Journal of Nuclear Medicine | 2011
Joon Yeun Park; Ilhan Lim; Yoon Choi; Hye Jin Kang; Byung Il Kim; Chang Woon Choi; Sang Moo Lim
The Journal of Nuclear Medicine | 2011
Jae Pil Hwang; Ilhan Lim; Byung Il Kim; Chang Woon Choi; Sang Moo Lim
Collaboration
Dive into the Byung Il Kim's collaboration.
Korea Research Institute of Bioscience and Biotechnology
View shared research outputs